MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
Volume 0.58M
Average 0.84M
MGTX Total Liabilities
Everything the company owes to creditors and other parties.
MeiraGTx Holdings plcNASDAQ: MGTX
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 58.6% from a year ago
Total liabilities stood at $302.79M at the end of Q1 FY2026, up 58.6% from a year earlier and up 21.0% from the prior quarter. Over 3 fiscal years it compounded at +7.7% a year.
Context
- Total liabilities amounted to 123.8% of total assets at the end of Q1 FY2026, up 38.5 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +58.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 250.22M USD
- Year-over-year change
- +23.9%
- 4-year CAGR
- +16.7%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 250.22M | +23.9% |
| FY2024 | 2024-12-31 | 201.92M | +7.1% |
| FY2023 | 2023-12-31 | 188.57M | -6.0% |
| FY2022 | 2022-12-31 | 200.5M | +48.8% |
| FY2021 | 2021-12-31 | 134.76M | — |
Total Liabilities vs competitors
How MGTX compares with its peers on the latest reported figures
- MGTX's Mar 2026 total liabilities of $302.79M is the 3rd highest of the 9 companies compared; the peer median is $139.68M.
- Its year-over-year change of +58.6% is the 2nd highest of 9, against a peer median of +21.4%.
- Total liabilities amounts to 123.8% of total assets for MGTX, versus a peer median of 60.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $629.36M | +10.1% | +39.8% | 80.8% | |
| Mar 2026 | $320.81M | +48.0% | +3.4% | 93.8% | |
| Mar 2026 | $302.79M | +58.6% | +7.7% | 123.8% | |
| Mar 2026 | $254.35M | +7.6% | -7.5% | 68.1% | |
| Jun 2026 | $141.52M | +44.8% | +46.7% | 9.4% | |
| Mar 2026 | $137.84M | -33.2% | -15.7% | 18.2% | |
| Mar 2026 | $61.07M | +32.7% | +26.0% | 11.9% | |
| Mar 2026 | $56.84M | +66.7% | +10.2% | 51.9% | |
| Mar 2026 | $51.1M | +5.3% | +17.1% | 89.8% | |
| Peer median (excluding MGTX) | $139.68M | +21.4% | +13.7% | 60.0% | |
Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 137.7M | 115.52M | 129.57M | 103.66M | 65.93M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 35.02M | 29.02M | 23.42M | 10.63M | 18.29M |
| Inventory | 0 | 0 | 0 | 385K | 0 |
| Other Current Assets | 2.42M | 1.67M | 1.02M | 2.02M | 1.53M |
| Total Current Assets | 183.24M | 154.34M | 159.62M | 123.52M | 91.76M |
| Property, Plant & Equipment (Net) | 126.29M | 154.09M | 156.24M | 135.65M | 141.93M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.57M | 2.08M | 1.12M | 821K | 578K |
| Long-term Investments | 6.66M | 6.33M | 6.77M | 6.75M | 6.75M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.4M | 1.4M | 3M | 3.01M | 3.41M |
| Total Non-current Assets | 136.92M | 163.9M | 167.12M | 146.23M | 152.67M |
| Total Assets | 320.16M | 318.24M | 326.74M | 269.75M | 244.43M |
| Account Payables | 15.35M | 16.62M | 16.04M | 23.59M | 10.07M |
| Short-term Debt | 0 | 0 | 0 | 0 | 24.65M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 21.82M | 15.12M | 2.93M | 4.83M | 1.78M |
| Other Current Liabilities | 6.03M | 16.23M | 41.28M | 12.1M | 63.09M |
| Total Current Liabilities | 68.13M | 82.07M | 67.08M | 60.78M | 122.56M |
| Long-term Debt | 0 | 71.03M | 72.12M | 73.22M | 49.69M |
| Deferred Tax Liabilities | 196K | 186K | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 43.05M | 27.44M | 34.02M | 57.58M | 65.12M |
| Other Non-current Liabilities | 3.03M | 2.44M | 2.4M | 2.82M | 1.4M |
| Total Non-current Liabilities | 66.64M | 118.43M | 121.49M | 141.14M | 127.67M |
| Total Liabilities | 134.76M | 200.5M | 188.57M | 201.92M | 250.22M |
| Common Stock | 2K | 2K | 2K | 3K | 3K |
| Retained Earnings | (340.59M) | (470.2M) | (554.23M) | (702.02M) | (816.22M) |
| Accumulated OCI | (2.67M) | 6.05M | (1.44M) | (3.72M) | 2.41M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 185.4M | 117.74M | 138.18M | 67.83M | (5.79M) |
| Total Debt | 23.73M | 92.25M | 89.26M | 84.8M | 88.69M |
| Net Debt | (113.97M) | (23.27M) | (40.3M) | (18.86M) | 22.76M |
MeiraGTx Holdings plc
NASDAQ:MGTX
Intrinsic Alpha fair value
Locked
Current Price
$8.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.